Your Article Summary
Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone
Corporate News Releases - The Healthcare Sales & Marketing Network, 09/08/06
The weight loss medication Xenical(R) (orlistat) has been shown to significantly reduce weight and improve the control of glucose levels in the blood (glycaemia) beyond the impact of weight loss alone in overweight and obese people with type 2 diabetes, according to study results presented at the International Congress on Obesity (ICO) in Sydney, Australia
| Previous Article | Next Article |
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial
European Heart Journal, 06/09/09
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841
Journal of Clinical Oncology, 06/15/09
Article Search
Sponsor


See Latest Articles


